Market by Type, Substrate Material, End User and Geography | Forecast 2019-2027
Triton Market Research has estimated the Latin America biochips market to show an upward trend in terms of revenue and grow rapidly with a CAGR of 13.77% in the forecasting years 2019-2027.
A biochip is an amalgamation of biosensors, microarrays and microfluidics-based systems and acts as an assortment of multiple tests on one single chip. Biochips provide multiplexing capacity to the analysis that in turn increases the test efficiency in molecular diagnostics.
The biochips market report includes key information about the key market strategies, regulatory framework, industry components, market opportunity insights, key insights, key impact analysis, Porter’s five force analysis, market definition, vendor scorecard, industry player positioning and the market attractiveness index.
The countries that have been analyzed for the Latin America biochips market are:
O Brazil
O Mexico
O Rest of Latin America
We provide additional customization based on your specific requirements. Request For Customization
The key funding received by biotechnology companies, private sector investments in biotechnology R&D activities and the increasing investments in the pharmaceutical sector for drug discovery are expected to boost the Latin America biochip market growth over the forecast period. The region is now targeting investment in bio-pharma and biotech industries specializing both in human health for the tropics, plant and animal husbandry for tropical agri-business.
Brazil is renowned globally for its research-related activities and investments in industrial biotechnology, particularly with respect to cellulosic sucrose and agriculture-based businesses. The Mexican pharmaceutical industry has constantly been transforming over the last few years, with the entry of international brands into the region. The country is the new cynosure for raising market share owing to the facilities it provides to organizations concerning the creation and protection of new formulae and/or technologies.
Newly-formed biotechnology trade federations in Latin America are increasing their membership base and rapidly gaining recognition on a global scale. In conjunction with the prosperity of commercial biotechnology in the region, arises the need to address a series of issues associated with public perception, regulatory framework and IP protection, financing mechanisms, workforce development among others. Government organizations and related public institutions are posed with the challenge of adjusting their policies and operations to address these changing demands.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA BIOCHIPS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.3. EVOLUTION
& TRANSITION OF BIOCHIPS
2.4. PORTER'S
FIVE FORCE ANALYSIS
2.5. MARKET
ATTRACTIVENESS MATRIX
2.6. INDUSTRY
COMPONENTS
2.7. REGULATORY
FRAMEWORK
2.8. VENDOR
SCORECARD
2.9. KEY
IMPACT ANALYSIS
2.10.
MARKET OPPORTUNITY INSIGHTS
2.11.
INDUSTRY PLAYER POSITIONING
2.12.
KEY MARKET STRATEGIES
2.13.
MARKET DRIVERS
2.13.1.
GROWTH IN PERSONALIZED
MEDICINES
2.13.2.
RISING INCIDENCES &
TREATMENT OF CANCER
2.13.3.
CONSTANT RISE IN HEALTHCARE
SPENDING WORLDWIDE
2.13.4.
INCREASING NUMBER OF
INVESTMENTS IN BIOTECHNOLOGY R&D
2.14.
MARKET RESTRAINTS
2.14.1.
INEQUALITIES IN HEALTHCARE
ACCESS
2.14.2.
INADEQUATE TECHNICAL AWARENESS
RELATED TO BIOCHIPS
2.14.3.
COMPLEXITY OF BIOLOGICAL
SYSTEMS
2.15.
MARKET OPPORTUNITIES
2.15.1.
DEVELOPMENTS IN BIOCHIPS
TECHNOLOGY
2.15.2.
ASIA PACIFIC TO OFFER
LUCRATIVE GROWTH OPPORTUNITIES
2.15.3.
WIDENING APPLICATION AREAS OF
BIOCHIPS
2.16.
MARKET CHALLENGES
2.16.1.
AVAILABILITY OF SUBSTITUTE
TECHNOLOGIES
2.16.2.
UNCLEAR REGULATORY GUIDELINES
2.16.3.
COST CONSTRAINTS
3. LATIN
AMERICA BIOCHIPS MARKET OUTLOOK – BY TYPE
3.1. DNA
CHIPS
3.1.1. AGRICULTURAL
BIOTECHNOLOGY
3.1.2. CANCER
DIAGNOSTICS & TREATMENT
3.1.3. DRUG
DISCOVERY
3.1.4. GENE
EXPRESSION
3.1.5. GENOMICS
3.1.6. SINGLE
NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
3.1.7. OTHER
DNA CHIPS
3.2. LAB
ON A CHIP
3.2.1. CLINICAL
DIAGNOSTICS
3.2.2. DRUG
DISCOVERY
3.2.3. GENOMICS
3.2.4. POINT
OF CARE & IN VITRO DIAGNOSIS
3.2.5. PROTEOMICS
3.2.6. OTHER
LAB ON A CHIP
3.3. PROTEIN
CHIPS
3.3.1. DIAGNOSTICS
3.3.2. DRUG
DISCOVERY
3.3.3. EXPRESSION
PROFILING
3.3.4. HIGH
THROUGHPUT SCREENING
3.3.5. PROTEOMICS
3.3.6. OTHER
PROTEIN CHIPS
3.4. OTHER
CHIPS
3.4.1. CELL
ARRAYS
3.4.2. TISSUE
ARRAYS
4. LATIN
AMERICA BIOCHIPS MARKET OUTLOOK - BY SUBSTRATE MATERIAL
4.1. GLASS
4.2. POLYMERS
4.3. SILICON
4.4. OTHER
SUBSTRATE MATERIALS
5. LATIN
AMERICA BIOCHIPS MARKET OUTLOOK - BY END USER
5.1. BIOTECHNOLOGY
AND PHARMACEUTICAL COMPANIES
5.2. HOSPITALS
AND DIAGNOSTICS CENTERS
5.3. ACADEMIC
AND RESEARCH INSTITUTE
6. LATIN
AMERICA BIOCHIPS MARKET - REGIONAL OUTLOOK
6.1. BRAZIL
6.2. MEXICO
6.3. REST
OF LATIN AMERICA
7. COMPETITIVE
LANDSCAPE
7.1. AGILENT
TECHNOLOGY INC.
7.2. BIOCHAIN
INSTITUTE INC.
7.3. BIOMERIEUX
SA
7.4. BIO-RAD
LABORATORIES INC.
7.5. CEPHEID
INC.
7.6. CYBRDI
INC.
7.7. FLUIDIGM
CORPORATION
7.8. GAMIDA
FOR LIFE GROUP
7.9. ILLUMINA
INC.
7.10.
IMGENEX
7.11.
MERCK GMBH
7.12.
ORIGENE TECHNOLOGIES INC.
7.13.
PERKINELMER INC.
7.14.
SAMSUNG ELECTRONICS INC.
7.15.
THERMO FISHER SCIENTIFIC INC.
8. METHODOLOGY
& SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1. MARKET
ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET
TABLE 2. VENDOR
SCORECARD OF BIOCHIPS MARKET
TABLE 3. REGULATORY
FRAMEWORK OF BIOCHIPS MARKET
TABLE 4. KEY STRATEGIC
DEVELOPMENTS IN BIOCHIPS MARKET
TABLE 5. NOTABLE
INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017
TABLE 6. LATIN AMERICA
BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
TABLE 7. LATIN AMERICA
BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)
TABLE 8. LATIN AMERICA BIOCHIPS
MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)
TABLE 9. LATIN AMERICA
BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)
TABLE 10. LATIN AMERICA
BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
FIGURE 1. LATIN AMERICA
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 2. PORTER’S FIVE
FORCE ANALYSIS OF BIOCHIPS MARKET
FIGURE 3. KEY IMPACT
ANALYSIS
FIGURE 4. TIMELINE OF
BIOCHIPS
FIGURE 5. MARKET
OPPORTUNITY INSIGHTS, BY TYPE, 2018
FIGURE 6. MARKET
OPPORTUNITY INSIGHTS, BY END USER, 2018
FIGURE 7. INDUSTRY
COMPONENTS OF BIOCHIPS MARKET
FIGURE 8. KEY PLAYERS
POSITIONING IN 2018 (%)
FIGURE 9. WORLDWIDE
HEALTHCARE SPENDING, BY REGIONS, 2014-2015 (% OF GDP)
FIGURE 10. COMPARISON
OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE
FIGURE 11. LATIN
AMERICA BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 12. LATIN
AMERICA DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $
MILLION)
FIGURE 13. LATIN
AMERICA DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN
$ MILLION)
FIGURE 14. LATIN
AMERICA DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 15. LATIN
AMERICA DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION)
FIGURE 16. LATIN
AMERICA DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
FIGURE 17. LATIN
AMERICA DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING,
2019-2027 (IN $ MILLION)
FIGURE 18. LATIN
AMERICA DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 19. LATIN
AMERICA BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)
FIGURE 20. LATIN
AMERICA LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 21. LATIN
AMERICA LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 22. LATIN
AMERICA LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
FIGURE 23. LATIN
AMERICA LAB ON A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2027
(IN $ MILLION)
FIGURE 24. LATIN
AMERICA LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
FIGURE 25. LATIN
AMERICA LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)
FIGURE 26. LATIN
AMERICA BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 27. LATIN
AMERICA PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 28. LATIN
AMERICA PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 29. LATIN
AMERICA PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)
FIGURE 30. LATIN
AMERICA PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $
MILLION)
FIGURE 31. LATIN
AMERICA PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
FIGURE 32. LATIN
AMERICA PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 33. LATIN
AMERICA BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 34. LATIN
AMERICA OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 35. LATIN
AMERICA OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 36. LATIN
AMERICA BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS)
FIGURE 37. LATIN
AMERICA BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)
FIGURE 38. LATIN
AMERICA BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)
FIGURE 39. LATIN
AMERICA BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $
MILLIONS)
FIGURE 40. LATIN
AMERICA BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES,
2019-2027 (IN $ MILLIONS)
FIGURE 41. LATIN
AMERICA BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $
MILLIONS)
FIGURE 42. LATIN
AMERICA BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $
MILLIONS)
FIGURE 43. LATIN
AMERICA BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 44. BRAZIL
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 45. MEXICO
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 46. REST OF
LATIN AMERICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)